Publications BPE group

501.

Talk

Genzel, Y.: ESACT Course on Cell Culture-based Viral Vaccines (8^th Edition): Overview on COVID-19 candidate vaccines. Introduction Exercise. ESACT Course 2023, Llafranc (Spain) (2023)

MPG.PuRe

502.

Talk

Genzel, Y.: ESACT Course on Cell Culture-based Viral Vaccines (8^th Edition):Upstream Process Intensification. ESACT Course 2023, Llafranc (Spain) (2023)

MPG.PuRe

503.

Talk

Genzel, Y.: ESACT Course on Cell Culture-based Viral Vaccines (8^th Edition):Upstream Process Development - From Master Seed to Production. ESACT Course 2023, Llafranc (Spain) (2023)

MPG.PuRe

504.

Talk

Genzel, Y.; Zinnecker, T. M.; Göbel, S.; Reichl, U.: Intensified cell-based virus production: A process development challenge for multiple cell-virus combinations. 16^th PEACe Conference, Sitges (Spain) (2023)

MPG.PuRe

505.

Talk

Genzel, Y.; Zinnecker, T. M.; Göbel, S.; Reichl, U.: Next-Generation Virus Production: From Clone, to AMBR, to Perfusion and Very High Virus Yield. International Society for Vaccines (ISV) Annual Congress, Lausanne (Switzerland) (2023)

MPG.PuRe

506.

Talk

Genzel, Y.; Zinnecker, T. M.; Göbel, S.; Reichl, U.: Increase in supply through use of new technologies for high yield vaccines. Flanders Vaccine, Brussels (Belgium) (2023)

MPG.PuRe

507.

Talk

Göbel, S.; Dallmeier, K.; Jordan, I.; de Jong, J.; Reichl, U.; Genzel, Y.: Intensified production for a yellow fever - ZIKA virus vaccine candicate. Democratization of biotherapies: new manufacturing modalities and intensification's, Oxford, UK (2023)

MPG.PuRe

508.

Talk

Göbel, S.; Jaén, K. E.; Pelz, L.; Reiter , M.; Altomonte, J.; Reichl, U.; Genzel, Y.: Intensifiying OSB processes for high titer virus production. 5^th large scale meeting: Orbital shaken bioreactors, Girona (Spain) (2023)

MPG.PuRe

509.

Talk

Hellwig, P.; Kautzner, D.; Benndorf, D.; Reichl, U.: Identification of newly synthesized proteins in microbial communities using BONCAT and click chemistry. 5^th International Metaproteomics Symposium, Avignon (France) (2023)

MPG.PuRe

510.

Talk

Hoang Son, T.; Lange, F.; Fattouh, N.; Rexer, T.; Reichl, U.: Process development for multi-gram-scale synthesis of nucleotide sugars using in-vitro multi-enzyme cascades. Eurocarb21 (The 21^st European Carbohydrate Symposium), Paris (France) (2023)

MPG.PuRe

511.

Talk

Hoang Son, T.; Wormstall, S.-T.; Rexer, T.; Reichl, U.: Development of an in-vitro multi-enzyme cascade for the synthesis of uridine diphosphate N-acetylgalactosamine using a DoE approach. GlycoBioTec 2023, Berlin, Germany (2023)

MPG.PuRe

512.

Talk

Jaén, K. E.: Glycoengineering toolbox. Festival of Biologics , Basel (Switzerland) (2023)

MPG.PuRe

513.

Talk

Küchler, J.; Opitz, P.; Rüdiger, D.; Kupke, S. Y.; Genzel, Y.; Benndorf, D.; Reichl, U.: Absolute quantification of influenza A virus proteins during single-round replication in different host cells. 6^th Workshop on Virus Dynamics, Nagoya (Japan) (2023)

MPG.PuRe

514.

Talk

Kupke, S. Y.; Dogra, T.; Pelz, L.; Hein, M. D.; Ndeir, N.; Rand, U.; Boehme, J.; Baelkner, M.; Kershaw, O.; Winkler, M. et al.; Cicin-Sain, L.; Bruder, D.; Pöhlmann, S.; Reichl, U.: Influenza A virus defective interfering particles as antiviral agents. 32^nd Annual Meeting of the Society for Virology (GfV), Ulm (Germany) (2023)

MPG.PuRe

515.

Talk

Nguyen, R. T.: Precision Biotransformation: Game-changer in Human Milk Oligosaccharides Production. Future Food-tech, London (UK) (2023)

MPG.PuRe

516.

Talk

Pelz, L.; Dogra, T.; Boehme, J.D.; Hein, M. D.; Marichal-Gallardo, P.; Genzel, Y.; Bruder, D.; Kupke, S. Y.; Reichl, U.: Influenza A virus OP7 defective interfering particles: Cell culture-based production and antiviral efficacy in vivo. Cell Culture Engineering (CCE) XVIII , Cancun (Mexico) (2023)

MPG.PuRe

517.

Talk

Pelz, L.; Genzel, Y.; Kupke, S. Y.; Reichl, U.: In-depth characterization and cell culture-based production of influenza A virus defective interfering particles. ACTIP fellowship session, Dublin (Ireland) (2023)

MPG.PuRe

518.

Talk

Pelz, L.; Rüdiger, D.; Dogra, T.; Alnaji, F. D.; Genzel, Y.; Brooke, C. B.; Kupke, S. Y.; Reichl, U.: Semi-continuous Propagation of Influenza A Virus and Its Defective Interfering Particles: Analyzing the Dynamic Competition To Select Candidates for Antiviral Therapy. Vir-AI-DIP Workshop, Hamburg (Germany) (2023)

MPG.PuRe

519.

Talk

Rexer, T.: eversyn - Delivering bioactive sugars at scale for nutrition & biopharma. Biofit 13^th Edidion, Marseille (France) (2023)

MPG.PuRe

520.

Talk

Rexer, T.: eversyn - Delivering bioactive sugars at scale for nutrition & biopharma. Pharmedi | Pharmed & Healthcare Vietnam 2023, Ho Chi Minh City (Vietnam) (2023)

MPG.PuRe

521.

Talk

Rexer, T.; Hoang Son, T.; Alcalá Orozco, E. A.; Juárez-Osorio, M.; Kleeberg, S.; Reichl, U.: Activated sugar for oligosaccharides synthesis. GlycoBioTec 2023, Berlin, Germany (2023)

MPG.PuRe

522.

Talk

Rüdiger, D.; Küchler, J.; Piasecka, J.; Pontes, C.; Kupke, S. Y.; Reichl, U.: OP7, a defective interfering particle with mutations: in vitro infection experiments, intracellular model, impact of mutations and mode of antiviral action. 6^th Workshop on Virus Dynamics, Nagoya (japan) (2023)

MPG.PuRe

523.

Talk

Rüdiger, D.; Pelz, L.; Hein, M. D.; Kupke, S. Y.; Reichl, U.: Multiscale model of influenza A virus and defective interfering particle co-infection in animal cell culture. Vir-AI-DIP Workshop, Hamburg (Germany) (2023)

MPG.PuRe

524.

Talk

Wenzel, L.; Rexer, T.; Reichl, U.: Synthesis of Synthetic Lipid-Linked Oligosaccharides for In-Vitro Glycoengineering of Hemagglutinin Peptides by a Cell-Free, Multi-Enzyme Cascade. GlycoBioTec 2023, Berlin, Germany (2023)

MPG.PuRe

525.

Talk

Wenzel, L.; Ruhnau, J.; Rexer, T.; Reichl, U.: Chemoenzymatic glycosylation of polypeptides using eukaryotic oligosaccharyltransferase and synthetic lipid-linked glycans. Glyco26, Taipei (Taiwan) (2023)

MPG.PuRe

526.

Talk

Zinnecker, T. M.; Badri, N.; Araujo, D.; Hinkelmann, A.; Thiele, K.; Reichl, U.; Genzel, Y.: Novel approach towards vaccine manufacturing: from single-cell cloning to high-yielding influenza virus production. 4^th Global Bioprocessing, Bioanalytics and ATMP Manufacturing Congress, Dublin (Ireland) (2023)

MPG.PuRe

527.

Talk

Zinnecker, T. M.; Badri, N.; Araujo, D.; Hinkelmann, A.; Thiele, K.; Reichl, U.; Genzel, Y.: A quest for the best influenza producing clonal MDCK cell line: intensifying by design of experiments, ambr15 and bench-top bioreactor cultivations. World Biopharm Forum 2023 - Democratisation of biotherapies: new manufacturing modalities and intensifications, Oxford (United Kingdom) (2023)

MPG.PuRe

528.

Talk

Zuniga-Banuelos, F. J.; Hoffmann, M.; Budimir, I.; Reichl, U.; Rapp, E.: New avenues for biomarker discovery in human blood plasma via an improved in-depth analysis of the low-abundant N-glycoproteome. GlycoBioTec 2023, Berlin, Germany (2023)

MPG.PuRe

529.

Talk

Genzel, Y.: ESACT Course on Cell Culture-based Viral Vaccines (7^th Edition):Upstream Process Development - From Master Seed to Production. ESACT Course 2022, Llafranc (Spain) (2022)

MPG.PuRe

530.

Talk

Genzel, Y.: ESACT Course on Cell Culture-based Viral Vaccines (7^th Edition):Upstream Process Intensification. ESACT Course 2022, Llafranc (Spain) (2022)

MPG.PuRe

531.

Talk

Genzel, Y.: ESACT Course on Cell Culture-based Viral Vaccines (7^th Edition): Overview on COVID-19 candidate vaccines. Introduction Exercise. ESACT Course 2022, Llafranc (Spain) (2022)

MPG.PuRe

532.

Talk

Genzel, Y.: ESACT Course on Cell Culture-based Viral Vaccines (7^th Edition): Exercise on vaccine design. ESACT Course 2022, Llafranc (Spain) (2022)

MPG.PuRe

533.

Talk

Göbel, S.; Pelz, L.; Behrendt, I.; Prömmel, M.; Altomonte, J.; Anderlei, T.; Bürgin, T.; Genzel, Y.; Reichl, U.: Scale-Down of an Ortbital Shaken Bioreactor: High Cell Density Cultivation in Perfusion Mode and Virus production. Single-Use Technologies V: Building the Future, Marseille, France (2022)

MPG.PuRe

534.

Talk

Gränicher, G.; Göbel, S.; Marichal-Gallardo, P.; Jordan, I.; Sandig, V.; Genzel, Y.; Reichl, U.: Integrated cell-culture based MVA virus production process with perfusion mode for vaccines or gene therapy. Value through intensified bioprocessing II, Oxford, United Kingdom (2022)

MPG.PuRe

535.

Talk

Gränicher, G.; Göbel, S.; Marichal-Gallardo, P.; Jordan, I.; Sandig, V.; Genzel, Y.; Reichl, U.: Integrated cell-culture based MVA virus production process with perfusion mode for vaccines or gene therapy. 27th ESACT Meeting, Lisbon (Portugal) (2022)

MPG.PuRe

536.

Talk

Hein, M.; Chawla, A.; Arora , P.; Cattaneo, M.; Winkler, M.; Pöhlmann, S.; Schughart, K.; Genzel, Y.; Kupke, S. Y.; Reichl, U.: Production of influenza A virus defective interfering particles in a high cell density perfusion cultivation with continuous virus harvesting. Vaccine Technology VIII, Sitges (Spain) (2022)

MPG.PuRe

537.

Talk

Hein, M.; Dogra, T.; Arora , P.; Rand , U.; Genzel, Y.; Cattaneo, M.; Winkler, M.; Cicin-Sain, L.; Bruder, D.; Schughart, K. et al.; Pöhlmann, S.; Kupke, S. Y.; Reichl, U.: Influenza A Virus-Derived Defective Interfering Particles for Antiviral Treatment. 27th ESACT Meeting, Lisbon (Portugal) (2022)

MPG.PuRe

538.

Talk

Huber, N.; Alcalá Orozco, E. A.; Rexer, T.; Reichl, U.; Klamt, S.: Dynamic Modeling and Optimization of a Cell-free Enzymatic Cascade for the Production of GDP-Fucose. ISGSB2022 Conference, Innsbruck, Austria (2022)

MPG.PuRe

539.

Talk

Juárez-Osorio, M.; Darr, A.; Volckmar, J.; Bruder, D.; Rexer, T.; Reichl, U.: Towards full control over protein glycosylation: In-vitro glycoengineering of Influenza A virus Hemagglutinin and SARS-CoV-2 spike protein. 32^nd Joint Glycobiology Meeting, Utrecht (The Netherlands) (2022)

MPG.PuRe

540.

Talk

Khesali Aghtaei, H.; Benndorf, D.; Reichl, U.: Biological methanation using a tubular foam bioreactor. Smart Process Systems Engineering 2022 Towards Sustainable & Circular Production Processes (SmartProSys 2022), Magdeburg, Germany (2022)

MPG.PuRe

541.

Talk

Khesali Aghtaei, H.; Benndorf, D.; Sczyrba, A.; Reichl, U.: Adaptation of a methanogenic community to demand-oriented biological methanation. 4th International Metaproteomics Symposium, Luxembourg, Luxembourg (2022)

MPG.PuRe

542.

Talk

Kupke, S. Y.; Hein, M.D.; Bdeir, N.; Rand, U.; Marichal-Gallardo, P.; Cicin-Sain, L.; Bruder, D.; Pöhlmann, S.; Schughart, K.; Reichl, U.: Influenza A Virus Defective Interfering Particles for Antiviral Treatment of the Influenza Disease and COVID-19. 31st Annual Meeting of the Society for Virology, online (2022)

MPG.PuRe

543.

Talk

Pelz, L.; Rüdiger, D.; Dogra, T.; Alnaji, F.G.; Genzel, Y.; Brooke, C.B.; Kupke, S. Y.; Reichl, U.: Long-Term Propagation of Influenza A Virus and Its Defective Interfering Particles: Analyzing Dynamic Competition to Select Antiviral Candidates. Vaccine Technology VIII, Sitges (Spain) (2022)

MPG.PuRe

544.

Talk

Pelz, L.; Rüdiger, D.; Dogra, T.; Alnaji, F. G.; Genzel, Y.; Brooke, C. B.; Kupke, S. Y.; Reichl, U.: Semi-Continuous propagation of Influenza A virus and its defective interfering particles: Analyzing the dynamic competition to select antiviral candidates. 27th ESACT Meeting, Lisbon (Portugal) (2022)

MPG.PuRe

545.

Talk

Rüdiger, D.; Küchler, J.; Pontes, C.; Kupke, S. Y.; Reichl, U.: Modeling the intracellular replication of a new type of defective interfering particle of influenza virus with genomic nucleotide substitutions. 12th European Conference on Mathematical and Theoretical Biology, Heidelberg (Germany) (2022)

MPG.PuRe

546.

Talk

Ruhnau, J.: Cell-free Glycoengineering of the recombinant SARS-CoV-2 spike glycoprotein. 15th Bratislava Symposium on Saccharides (15BSS) , Smolenice (Slovakia) (2022)

MPG.PuRe

547.

Talk

Zinnecker, T. M.; Behrendt, I.; Lau , M.; Hinkelmann, A.; Thiele, K.; Badri, N.; Araujo, D.; Genzel, Y.; Reichl, U.: Automated single-cell cloning in chemically defined medium for new suspension MDCK cell lines and scale-down of influenza A virus production into ambr^®15 microbioreactors. Vaccine Technology VIII, Sitges (Spain) (2022)

MPG.PuRe

548.

Talk

Genzel, Y.: ESACT Course on Cell Culture-based Viral Vaccines (6^th Edition):Cells, Upstream Processing and Process Intensification. ESACT Course 2021, Virtual Meeting (2021)

MPG.PuRe

549.

Talk

Genzel, Y.: ESACT Course on Cell Culture-based Viral Vaccines (6^th Edition): Overview on COVID-19 candidate vaccines. ESACT Course 2021, Virtual Meeting (2021)

MPG.PuRe

550.

Talk

Genzel, Y.: ESACT Course on Cell Culture-based Viral Vaccines (6^th Edition): Exercise on COVID-19 antigen design options and vaccination platforms. ESACT Course 2021, Virtual Meeting (2021)

MPG.PuRe

Talk (365)